Individuals Stopping Weight-Loss Medications Regain Weight Far More Rapidly Compared to Those on Conventional Diets

A recent study reveals that individuals who discontinue popular slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass far faster than those who end conventional diet and exercise programs.

Published data in a leading health publication demonstrates that while obese individuals can lose substantial amounts of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month once they quit.

"Individuals using these medications must be aware of the danger of quick weight regain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.

That rate of recovery suggests a reversion to pre-treatment weight within about a year and a half.

Weighing Therapies

The study, which reviewed dozens of studies involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with other pills.

The team point out that individuals who shed pounds through lifestyle changes alone typically experience a less rapid weight regain—around 100 grams monthly—post-intervention.

Understanding the Fast Rebound

Doctors suggest the mode of action of the injections is key to understanding the accelerated weight return.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing GLP-1 levels far above than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.

"Discontinuation of this GLP-1 'fix' leads to appetite is no longer kept in check, making binge eating much more probable."

A Lifelong Issue?

Medical guidelines suggest the jabs for people with obesity-related health risks, alongside prescribed lifestyle changes.

Many experts contend that, given the significant potential of weight regain, the therapy is often life-long.

This perspective is reinforced by pharmaceutical companies, who state that the results "highlight the long-term nature of excess weight," akin to managing conditions like diabetes.

User Experiences

Individuals who have discontinued the medication describe a intense resurgence of hunger.

"It was like a trigger activating and you become starving," described one woman.

The struggle is exacerbated if users have not established permanent lifestyle or habit changes during therapy.

Growing Interest

Survey data suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.

• Use is higher among women compared to males.
• The 40s and 50s demographic shows the highest level of interest.
• Many access the drugs through private healthcare rather than the NHS.

Finally, researchers emphasize that while the jabs are effective agents for shedding pounds, they are not a magic solution and maintained weight loss hinges on combined lifestyle support.